• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Minerals
    Tech
    Life Science
    Pharmaceutical Market
    Pharmaceutical News
    Pharmaceutical Stocks
    • Pharmaceutical Market
    • Pharmaceutical News
    • Pharmaceutical Stocks
    pharmaceutical investing

    SHAREHOLDER ALERT: WeissLaw LLP Reminds XLRN, JMP, ECHO, and KDMN Shareholders About Its Ongoing Investigations

    Written by Investing News Network
    |
    Oct. 07, 2021 11:33AM PST
    If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this notice or your rights or interests, please contact: Joshua Rubin, Esq. WeissLaw LLP 305 Broadway, 7 th Floor New York NY  10007  682-3025 593-4771 stockinfo@weisslawllp.com Acceleron Pharma Inc. WeissLaw LLP is investigating possible breaches of fiduciary duty and other ...

    -

    If you own shares in any of the companies listed above and
    would like to discuss our investigations or have any questions concerning
    this notice or your rights or interests, please contact:

    Joshua Rubin, Esq.
    WeissLaw LLP
    305 Broadway, 7 th Floor
    New York , NY  10007
    (212) 682-3025
    (888) 593-4771
    stockinfo@weisslawllp.com

    Acceleron Pharma Inc. (NASDAQ: XLRN)

    WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Acceleron Pharma Inc. (NASDAQ: XLRN) in connection with the proposed acquisition of the Company by Merck & Co., Inc. ("Merck") (NYSE: MRK), via a tender offer.  Under the terms of the merger agreement, XLRN shareholders will receive $180.00 per share in cash for each share of XLRN common stock that they hold.  If you own XLRN shares and wish to discuss this investigation or your rights, please call us or visit our website: https://www.weisslaw.co/news-and-cases/xlrn

    JMP Group LLC (NYSE: JMP)

    WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of JMP Group LLC (NYSE: JMP) in connection with the proposed acquisition of the company by Citizens Financial Group Inc.  Under the terms of the merger agreement, JMP shareholders will receive $7.50 per share in cash for each share of JMP common stock that they hold.  If you own JMP shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/jmp

    Echo Global Logistics, Inc. (NASDAQ: ECHO)

    WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Echo Global Logistics, Inc. (NASDAQ: ECHO) in connection with the proposed acquisition of the company by funds managed by The Jordan Company, L.P.  Under the terms of the merger agreement, ECHO shareholders will receive $48.25 per share in cash for each share of ECHO stock that they hold.  If you own ECHO shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/echo

    Kadmon Holdings, Inc. (NASDAQ: KDMN)

    WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Kadmon Holdings, Inc. (NASDAQ: KDMN) in connection with the proposed acquisition of the company by Sanofi ("Sanofi").  Under the terms of the merger agreement, the company's shareholders will receive $9.50 per share in cash for each share of KDMN stock that they hold.  If you own KDMN shares and wish to discuss this investigation or your rights, please call us at one of the numbers listed above or visit our website: https://www.weisslaw.co/news-and-cases/kadmon-holdings-inc

    View original content to download multimedia: https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-reminds-xlrn-jmp-echo-and-kdmn-shareholders-about-its-ongoing-investigations-301395829.html

    SOURCE WeissLaw LLP

    News Provided by Canada Newswire via QuoteMedia

    pharmaceutical investing
    The Conversation (0)

    Go Deeper

    AI Powered

    Change of Company Name and ASX Ticker

    Kutcho Copper Drills 11.5m of 1.9% CuEq* (including 1.5m of 6.6% CuEq*) at Esso Below Existing Resource Model; Drills 21.9m of 3.3% CuEq* and 10.4m of 5.3% CuEq* at Main Deposit

    Latest News

    More News

    Outlook Reports world

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Pharmaceutical Investing Stocks

    InMed Pharmaceuticals

    InMed Pharmaceuticals (INM)
    INM
    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES